1. ML Yu, et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine 2015 (94): 13: e690
C型肝炎抗體 篩檢涵蓋率
C型肝炎抗體 陽性率
C型肝炎RNA 檢驗率
C型肝炎 診斷率
C型肝炎 治療率
0
100
0
100
0
100
0
100
0
100
0
100
2023.06
2023.09
2023.12
C型肝炎 抗體篩檢涵蓋率
99.9%
C型肝炎 診斷率
84.8%
C型肝炎 治療率
95.8%
C肝診斷率*治療率 (獲治療比例)1
81.2%
1. ML Yu, et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine 2015 (94): 13: e690
C型肝炎抗體 篩檢涵蓋率
C型肝炎抗體 陽性率
C型肝炎RNA 檢驗率
C型肝炎 診斷率
C型肝炎 治療率
0
100
0
100
0
100
0
100
0
100
0
100
2023.06
2023.09
2023.12
C型肝炎 抗體篩檢涵蓋率
99.9%
C型肝炎 診斷率
84.8%
C型肝炎 治療率
95.8%
C肝診斷率*治療率 (獲治療比例)1
81.2%
1. ML Yu, et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine 2015 (94): 13: e690